Evidence map›Paper›PMID 37644568›Full record

ArticleOrphanet journal of rare diseases2023

Transition of patients with metabolic bone disease from paediatric to adult healthcare services: current situation and proposals for improvement.

Enrique Casado, Carlos Gómez-Alonso, Guillem Pintos-Morell, Rosa Bou-Torrent, Ana Coral Barreda-Bonis, José Vicente Torregrosa, José Jesús Broseta-Monzó, Pedro Arango-Sancho, Sara Chocrón-de-Benzaquen, Yoko Olmedilla-Ishishi and 1 more

Abstract readConsensus Statement
In one paragraph

Article in Orphanet journal of rare diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Enrique CasadoRheumatology Department, Hospital Universitario Parc Taulí, Sabadell, Barcelona, Spain.ORCID http://orcid.org/0000-0001-8839-6430
Carlos Gómez-AlonsoBone and Mineral Metabolism Clinical Management Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.
Guillem Pintos-MorellHereditary Metabolic Diseases, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Rosa Bou-TorrentPaediatric Rheumatology Unit, Hospital Sant Joan de Déu, Barcelona, Spain.
Ana Coral Barreda-BonisPaediatric Endocrinology Department, Hospital Universitario la Paz, Madrid, Spain.
José Vicente TorregrosaDepartment of Nephrology and Renal Transplant, Hospital Clínic de Barcelona, Barcelona, Spain.
José Jesús Broseta-MonzóDepartment of Nephrology and Renal Transplant, Hospital Clínic de Barcelona, Barcelona, Spain.
Pedro Arango-SanchoDepartment of Paediatric Nephrology, Hospital Sant Joan de Déu, Barcelona, Spain.
Sara Chocrón-de-BenzaquenDepartment of Paediatric Nephrology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Yoko Olmedilla-IshishiMedical Department, Kyowa Kirin Farmacéutica, S.L., Madrid, Spain.
Begoña Soler-LópezMedical Department, E-C-BIO, S.L., c/Rosa de Lima, 1, Edificio ALBA, Office 016, 28230, Las Rozas, Madrid, Spain. bsoler@ecbio.net.ORCID http://orcid.org/0000-0001-5853-2307

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are currently no models for the transition of patients with metabolic bone diseases (MBDs) from paediatric to adult care. The aim of this project was to analyse information on the experience of physicians in the transition of these patients in Spain, and to draw up consensus recommendations with the specialists involved in their treatment and follow-up.

methodsThe project was carried out by a group of experts in MBDs and included a systematic review of the literature for the identification of critical points in the transition process. This was used to develop a questionnaire with a total of 48 questions that would determine the degree of consensus on: (a) the rationale for a transition programme and the optimal time for the patient to start the transition process; (b) transition models and plans; (c) the information that should be specified in the transition plan; and (d) the documentation to be created and the training required. Recommendations and a practical algorithm were developed using the findings. The project was endorsed by eight scientific societies.

resultsA total of 86 physicians from 53 Spanish hospitals participated. Consensus was reached on 45 of the 48 statements. There was no agreement that the age of 12 years was an appropriate and feasible point at which to initiate the transition in patients with MBD, nor that a gradual transition model could reasonably be implemented in their own hospital. According to the participants, the main barriers for successful transition in Spain today are lack of resources and lack of coordination between paediatric and adult units.

conclusionsThe TEAM Project gives an overview of the transition of paediatric MBD patients to adult care in Spain and provides practical recommendations for its implementation.

Indexed as

Bone Diseases, MetabolicTransition to Adult CareAdultAlgorithmsChildDelivery of Health CareHumansMetabolic bone diseasePaediatricTransitional careX-linked hypophosphataemia (XLH)

Identifiers

PMID37644568
PMCPMC10463506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.